Challenges with Cold Chain Shipping Live Cell Therapies: Likarda Konnect

Webinar: Challenges with Cold Chain Shipping of Live Cell Therapies

Wednesday, December 13 | 11am ET/8am PT | Online

Cell therapy developers face significant logistical and cell viability challenges to successfully manufacture and transport their therapies. The current standard is to use liquid nitrogen to transport these therapies, which presents significant cost and hazard burdens.

Is it possible to make transporting these live cell therapies cost-efficient and less hazardous while increasing cell viability?

At this webinar, attendees can expect to hear about:

  • Current best practice in cell therapy transportation
  • Unmet needs in the cold chain shipping process
  • New technologies beyond traditional cryopreservants to optimize the freeze/thaw process for cells

Meet the Speakers

Lisa Stehno-Bittel, PhD

President and Founder

Dr. Stehno-Bittel is founder of Likarda and serves as the President. She launched the company over seven years ago based on her extensive research and built a dedicated team of scientists at Likarda that advance the science and technology of CSS drug delivery and logistical optimization for cell therapy and biologics. That innovative spirit continues with numerous new inventions and awards including Ingram’s Magazine’s “50 Kansans You Should Know” and the Women in Medicine and Science Sirridge award for female role models. Most recently the Women We Admire Organization named Stehno-Bittel one of the Top 50 Women Leaders in the state.

Marcie Finney

Cleveland Cord Blood Center

With over 20 years of experience, Marcie Finney has played a pivotal role in educating medical personnel, supporting families, and driving the growth of cord blood applications. As the Executive Director of the Cleveland Cord Blood Center, she has led the organization through significant milestones, secured vital funding, established invaluable partnerships, and fostered the ever-growing expansion of cord blood usage in patient treatment and clinical research.

Her expertise extends to both science and business, as she holds an Executive MBA from the Weatherhead School of Management at Case Western Reserve University, complementing her Master of Science in Chemistry. Marcie Finney’s passion for health, technology, and business is evident in her influence in shaping national strategies for umbilical cord blood banking and showcases her commitment to the betterment of patient care and medical science. She serves on the Advisory Council on Blood Stem Cell Transplantation (ASBSCT), is on the Executive Committee of the Cord Blood Association as Treasurer, is the co-Chair of the Cord Blood Advisory Group, and as the Secretary of Goodwill Industries of Northeast Ohio and East Central Ohio, she supports programs aimed at removing barriers to employment and promoting independence for individuals in need.

Access this on-demand recording today

Important Registration Note: We kindly suggest confirming in advance that your Zoom sign-in works and that your Zoom software is up to date. If you do not have a commercial Zoom account, please create a FREE account here.

We’re here to help you improve the efficacy of your cell therapies and invite you to follow us on social media for the latest updates.